The slope of the adverse event dose-response may be steeper than for analgesia.
Scenario S6 evaluated permanent, instead of single-event dose reductions.
If more than one episode of hypoglycemia occurred in a week, the GL dose was decreased by 2 units or the LY2605541 dose was decreased to 80% of the pre-event dose on the first day and then 90% thereafter.
Patients taking GL who experienced at least or more than two hypoglycemic episodes had their dose decreased by 2 IU; and for patients taking LY2605541, the dose was decreased to 80% of the pre-event dose on the first day and 90% thereafter.
If dogs experienced grade 3 or greater adverse events, dose reduction or delay was instituted.
In patients where the dose has initially been reduced for mild adverse events, dose escalations may be considered (Table 4).
Owing to adverse events, dose adjustments for one or both agents (to <80% of initial doses) were reported in 41% of patients.
In case when total accidental design basis event (DBE) dose (involving about 80% soft beta radiation) is simulated by 60Co-gamma radiation the conservatism is reached.
The data will be presented in a form suitable for comparison with models of nuclear fragmentation and transport, including linear energy transfer (LET) spectrum, fluence for iron and fragments, event-tack- and event-dose-averaged LET, total dose and iron contribution to dose.
Relevant information (design, objectives, patients' characteristics, outcomes, adverse events, dosing, etc) was analyzed.
Assess the value of the Key Events Dose-Response Frame-work as applied to retinol.
